Muneto Mogi

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 206 citations · Full text

Immunology, Biological Therapy, Dermatology +23

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 162 citations · Full text

Molecular Physiology, Kidney Research, Medicine +8

Structure of neprilysin in complex with the active metabolite of sacubitril

Nikolaus Schiering, A. D’Arcy, Frédéric Villard et al. · Scientific Reports · 2016 · 66 citations · Full text

Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki et al. · Journal of Medicinal Chemistry · 2020 · 57 citations

Efficient Route to 4a-Methyltetrahydrofluorenes:  A Total Synthesis of (±)-Dichroanal B via Intramolecular Heck Reaction

Muneto Mogi, Hirofumi Takita, Tetsuya Kajimoto et al. · The Journal of Organic Chemistry · 2006 · 51 citations